HIV Prevention Has An Equity Problem. Here’s What Needs to Change

Michael Chancley, communications director, PrEP4All, and PrEP person.

AIDSVu.org: “Local Knowledge: Louisiana.”

CDC.gov: “HIV and Women of all ages: HIV Diagnoses,” “HIV Surveillance Knowledge Tables. Desk 3a,” “PrEP Effectiveness,”

Fda.gov: “FDA Approves Initial Injectable Treatment for HIV Pre-Exposure Prophylaxis,” Dec. 20, 2021, “FDA approves next drug to avoidance HIV infection as part of ongoing efforts to stop the HIV epidemic,” Oct. 2, 2019, “FDA approves Cabenuva and Vocabria for Therapy of HIV-1 Infection.”

Dawn K. Smith, MD, epidemiologist and health-related officer, CDC.

HIV.gov: “FDA approves 1st drug for lowering the risk of sexually acquired HIV an infection,” July 16, 2021.

Kimberly Smith, MD, senior vice president and head of exploration and growth, ViiV Healthcare.

Maggie Czarnogorski, head of innovation and implementation science, ViiV Healthcare.

Dora Martinez, MD, health care director, Westbrook Clinic, McAllen, TX.

DataUSA.io: “Cameron County, TX.”

PleasePrEPMe.org: “Harlingen, TX,” “McAllen, TX,” “Brownsville, TX.”

AIDSVu.org: “Cameron County, TX.”

Audrey Abernathy, head of communications and external affairs, ViiV Health care.

Sean Bland, JD, senior associate, Infectious Disorders Initiative, O’Neill Institute for Countrywide and World-wide Wellness Law, Georgetown Regulation.

AmfAR.org: “Long-Performing HIV Cure and Avoidance Are Coming: Preparing for Likely Activity Changers.”

Melinda Stubbee, spokesperson, ViiV Health care

JAMA Community Open: “Characterization of HIV Preexposure Prophylaxis Use Behaviors and HIV Incidence amid US older people in an built-in health treatment program.”

Meeting on Retroviruses and Opportunistic Infections: “PrEP Use and Referral: Black Partners of Persons With HIV in Companion Expert services, 2019.”

AIDS and Conduct: “The effect of client race on scientific selections connected to prescribing HIV pre-publicity prophylaxis (PrEP): Assumptions about sexual possibility compensation and implications for access.”